Interaction of reactive nitrogen and oxygen intermediates in HL60 and dimethylsulphoxide-differentiated HL60 cells

Leukemia Research

Volumn 20, Issue 3, 1996, Pages 271-279

  Ahmed, Nuzhat ^a,b   Weidemann, Maurice J ^a  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b MALAGHAN INSTITUTE OF MEDICAL RESEARCH   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOCHROME C; DIMETHYL SULFOXIDE; LUMINOL; N(G) METHYLARGININE; NITRATE; NITRIC OXIDE; NITROGEN; PHORBOL 13 ACETATE 12 MYRISTATE; REACTIVE NITROGEN METABOLITE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN HL 60; CHEMICAL INTERACTION; CHEMOLUMINESCENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; REDUCTION;

EID: 0029866558     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00145-X     Document Type: Article

References (29)

1. Moncada S. & Higgs E. A. (1991) Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21, 361.
2. McCall B., Boughton-Smith N. K., Palmer R. M. J., Whittle B. J. R. & Moncada S. (1989) Synthesis of nitric oxide from L-arginine by neutrophils. Biochem. J. 261, 293.
3. Nathan C. F. & Hibbs J. B. Jr (1991) Role of nitric oxide synthesis in macrophage microbicidal activity. Curr. Opin. Immunol. 3, 65.
4. Greenberger J. S. (1991) The hematopoietic micro-environment. Crit. Rev. Oncol. Hematol. 11, 65.
5. Albina J. E., Caldwell M. D., Williams H. L. Jr & Mills C. D. (1989) Regulation of macrophage functions by L-arginine. J. expl Med. 169, 1021.
6. Moncada S., Radomski M. W. & Palmer R. M. J. (1988) Endothelium-derived relaxing factor: identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem. Pharmacol. 37, 2495.
7. Rubanyi G. M., Ho E. H., Cantor E. H., Lumma W. C. & Botelho L. H. P. (1991) Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes. Biochem. Biophys. Res. Commun. 181, 1392.
8. Ahmed N., Williams J. F. & Weidemann M. J. (1991) The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate. Biochem. Int. 23, 591.
9. Ahmed N., Williams J. F. & Weidemann M. J. (1993) Glycolytic, glutaminolytic and pentose-phosphate pathways in promyelocytic HL60 and DMSO-differentiated HL60 cells. Biochem. Mol. Biol. Int. 29, 1055.
10. Ahmed N. & Weidemann M. J. (1994) Purine metabolism in promyelocytic HL60 and dimethylsulphoxide-differentiated HL60 cells. Leukemia Res. 18, 441.
11. Magrinat G., Mason S. N., Shami, P. J. & Weinberg, J. B. (1992) Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood 80, 1880.
12. Oberley L. W. & Buettner G.R. (1979) Role of superoxide dismutase in cancer. Cancer Res. 39, 1141.
13. Efron D. T., Stephen J. K., Regan M. C., Wasserkrug H. L. & Barbul A. (1991) Nitric oxide generation from L-arginine is required for optimal human peripheral blood lymphocyte DNA synthesis. Surgery 110, 327.
14. Seth P., Kumari M., Dikshit M. & Srimal R. C. (1994) Modulation of rat peripheral polymorphonuclear leukocyte by nitric oxide and arginine. Blood 84, 2741.
15. Wright C. D., Mulsch A., Busse R. & Osswald, H. (1989) Generation of nitric oxide by human neutrophils. Biochem. Biophys. Res. Commun. 160, 813.
16. Green L. C., Luzuriaga K. R., Wagner D. A., Rand W., Istfan N., Young V. R. & Tannenbaum. S. R. (1981) Nitrate biosynthesis in man. Proc. natn. Acad. Sci. USA 78, 7764.
17. Albina J. E. & William L. H. (1991) Suppression of lymphocyte proliferation through the nitric oxide synthesizing pathway. J. Surg. Res. 50, 403.
18. Denham S. & Rowland I. J. (1991) Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide. Clin. exp. Immunol. 87, 157.
19. Hibbs J. B. Jr, Vavrin Z. & Taintor R. R. (1987) L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J. Immunol. 138, 550.
20. Lepoivre M., Chenais B., Yapo A., Lemaire G., Thelander L. & Tenu J. P. (1990) Alterations of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J. Biol. Chem. 265, 14143.
21. Lepoivre M., Fieschi F., Coves J., Thelander L. & Fontecave M. (1991) Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179, 442.
22. Peterson D. A. (1992) The nonspecificity of specific nitric oxide synthase inhibitor. Biochem. Biophys. Res. Commun. 187, 797.
23. Stuehr D. J. & Nathan C. F. (1989) Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. expl Med. 169, 1543.
24. Beckman J. S., Beckman T. W., Chen J., Marshall P. A. & Freeman B. A. (1990) Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc. natn. Acad. Sci. USA 87, 1620.
25. Ischiropoulos H., Zhu L. & Beckman J. S. (1992) Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298, 446.
26. Radi R., Cosgrove P., Beckman J. S. & Freeman B. A. (1993) Peroxynitrite-induced luminol chemiluminescence. Biochem. J. 290, 51.
27. Wang J., Komarov P. & De Groot H. (1991) Contribution of nitric oxide synthase to luminol-dependent chemiluminescence generated by phorbol-ester-activated Kupffler cells. Biochem. J. 279, 311314.
28. 4. FEBS Lett. 244, 357360.
29. Clancy R. M., Leszczynska-Piziak J. & Abramson S. B. (1992) Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J. Clin. Invest. 90, 1116.